메뉴 건너뛰기




Volumn 20, Issue 4, 2012, Pages 161-166

Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation

Author keywords

Atrial; Fibrillation; Left atrial appendage; Percutaneous; Prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG; WARFARIN; WATCHMAN;

EID: 84859649310     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0236-8     Document Type: Article
Times cited : (10)

References (25)
  • 1
    • 33747052359 scopus 로고    scopus 로고
    • Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
    • Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-25.
    • (2006) Circulation , vol.114 , pp. 119-125
    • Miyasaka, Y.1    Barnes, M.E.2    Gersh, B.J.3
  • 2
    • 0030855939 scopus 로고    scopus 로고
    • Incidence of and risk factors for atrial fibrillation in older adults
    • Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-61.
    • (1997) Circulation , vol.96 , pp. 2455-2461
    • Psaty, B.M.1    Manolio, T.A.2    Kuller, L.H.3
  • 3
    • 4844222283 scopus 로고    scopus 로고
    • Lifetime risk for development of atrial fibrillation: The Framingham Heart Study
    • Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042-6.
    • (2004) Circulation , vol.110 , pp. 1042-1046
    • Lloyd-Jones, D.M.1    Wang, T.J.2    Leip, E.P.3
  • 4
    • 0030051404 scopus 로고    scopus 로고
    • Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
    • Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755-9.
    • (1996) Ann Thorac Surg , vol.61 , pp. 755-759
    • Blackshear, J.L.1    Odell, J.A.2
  • 5
    • 0032779161 scopus 로고    scopus 로고
    • Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)
    • Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr. 1999;12:1080-7.
    • (1999) J Am Soc Echocardiogr , vol.12 , pp. 1080-1087
    • Goldman, M.E.1    Pearce, L.A.2    Hart, R.G.3
  • 6
    • 41849133989 scopus 로고    scopus 로고
    • Reducing the risk for stroke in patients who have atrial fibrillation
    • Garcia DA, Hylek E. Reducing the risk for stroke in patients who have atrial fibrillation. Cardiol Clin. 2008;26:267-75.
    • (2008) Cardiol Clin , vol.26 , pp. 267-275
    • Garcia, D.A.1    Hylek, E.2
  • 7
    • 0029745023 scopus 로고    scopus 로고
    • Stroke severity in atrial fibrillation. The framingham study
    • Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The framingham study. Stroke. 1996;27:1760-4.
    • (1996) Stroke , vol.27 , pp. 1760-1764
    • Lin, H.J.1    Wolf, P.A.2    Kelly-Hayes, M.3
  • 8
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 9
    • 57149140461 scopus 로고    scopus 로고
    • Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
    • Connolly SJ, Pogue J, Eikelboom J, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029-37.
    • (2008) Circulation , vol.118 , pp. 2029-2037
    • Connolly, S.J.1    Pogue, J.2    Eikelboom, J.3
  • 10
    • 0034116581 scopus 로고    scopus 로고
    • Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation
    • Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke. 2000;31:822-7.
    • (2000) Stroke , vol.31 , pp. 822-827
    • Gage, B.F.1    Boechler, M.2    Doggette, A.L.3
  • 11
    • 34249715284 scopus 로고    scopus 로고
    • Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    • Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689-96.
    • (2007) Circulation , vol.115 , pp. 2689-2696
    • Hylek, E.M.1    Evans-Molina, C.2    Shea, C.3    Henault, L.E.4    Regan, S.5
  • 12
    • 0032505605 scopus 로고    scopus 로고
    • Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
    • Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167-71.
    • (1998) Lancet , vol.352 , pp. 1167-1171
    • Sudlow, M.1    Thomson, R.2    Thwaites, B.3    Rodgers, H.4    Kenny, R.A.5
  • 13
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (ESC)
    • Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC). Europace. 2010;12:1360-420.
    • (2010) Europace , vol.12 , pp. 1360-1420
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3
  • 14
    • 59749099384 scopus 로고    scopus 로고
    • Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter
    • Boersma LV, Wijffels MC, Oral H, Wever EF, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm. 2008;5:1635-42.
    • (2008) Heart Rhythm , vol.5 , pp. 1635-1642
    • Boersma, L.V.1    Wijffels, M.C.2    Oral, H.3    Wever, E.F.4    Morady, F.5
  • 16
    • 34249682101 scopus 로고    scopus 로고
    • Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    • Nieuwlaat R, Olsson SB, Lip GY, et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. AmHeart J. 2007;153:1006-12.
    • (2007) AmHeart J , vol.153 , pp. 1006-1012
    • Nieuwlaat, R.1    Olsson, S.B.2    Lip, G.Y.3
  • 17
    • 34547838462 scopus 로고    scopus 로고
    • Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: Results from the IN-RANGE study
    • Parker CS, Chen Z, Price M, et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med. 2007;22:1254-9.
    • (2007) J Gen Intern Med , vol.22 , pp. 1254-1259
    • Parker, C.S.1    Chen, Z.2    Price, M.3
  • 18
    • 33947587475 scopus 로고    scopus 로고
    • Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation
    • Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49:1490-5.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1490-1495
    • Sick, P.B.1    Schuler, G.2    Hauptmann, K.E.3
  • 19
    • 78149232687 scopus 로고    scopus 로고
    • PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: Results from the European PLAATO study
    • Bayard YL, Omran H, Neuzil P, et al. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention. 2010;6:220-6.
    • (2010) EuroIntervention , vol.6 , pp. 220-226
    • Bayard, Y.L.1    Omran, H.2    Neuzil, P.3
  • 20
    • 33646081030 scopus 로고    scopus 로고
    • The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial
    • Fountain RB, Holmes DR, Chandrasekaran K, et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J. 2006;151:956-61.
    • (2006) Am Heart J , vol.151 , pp. 956-961
    • Fountain, R.B.1    Holmes, D.R.2    Chandrasekaran, K.3
  • 21
    • 68349151861 scopus 로고    scopus 로고
    • Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised noninferiority trial
    • Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised noninferiority trial. Lancet. 2009;374:534-42.
    • (2009) Lancet , vol.374 , pp. 534-542
    • Holmes, D.R.1    Reddy, V.Y.2    Turi, Z.G.3
  • 22
    • 79751531253 scopus 로고    scopus 로고
    • Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry
    • Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417-24.
    • (2011) Circulation , vol.123 , pp. 417-424
    • Reddy, V.Y.1    Holmes, D.2    Doshi, S.K.3    Neuzil, P.4    Kar, S.5
  • 23
    • 79958126202 scopus 로고    scopus 로고
    • Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
    • Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-72.
    • (2011) Circulation , vol.123 , pp. 2363-2372
    • Eikelboom, J.W.1    Wallentin, L.2    Connolly, S.J.3
  • 24
    • 77956977472 scopus 로고    scopus 로고
    • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial
    • Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376:975-83.
    • (2010) Lancet , vol.376 , pp. 975-983
    • Wallentin, L.1    Yusuf, S.2    Ezekowitz, M.D.3
  • 25
    • 70349388083 scopus 로고    scopus 로고
    • Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses
    • Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2:349-61.
    • (2009) Circ Arrhythm Electrophysiol , vol.2 , pp. 349-361
    • Calkins, H.1    Reynolds, M.R.2    Spector, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.